Alvotech (ALVO) Gets New ‘Buy’ Reco. Should Investors Follow?
Alvotech (NASDAQ:ALVO) extended its winning streak to a 5th consecutive day on Monday, jumping 18.51 percent to finish at $5.25 apiece, after the Bank of America (BofA) raised its price target for the company. In its recent coverage, BofA initiated a buy recommendation on Alvotech shares with a price target of $7, amid the closure […]
Yahoo10 days agoALVO
12 Health Care Stocks Moving In Monday's Intraday Session
Gainers Innovative Eyewear (NASDAQ:LUCY) stock rose 63.6% to $1.12 during Monday's regular session. The market value of their outstanding shares is at $5.8 million. Picard Medical (AMEX:PMI) shares increased by
Benzinga11 days agoALVO
Crude Oil Down 3%; XPeng Shares Fall After Q2 Results
US stocks traded mixed with the Dow Jones index gaining over 150 points. Consumer staples shares jumped while information technology stocks fell. XPeng Inc shares fell 7% due to wider than expected loss and lower revenue outlook.
Benzinga11 days agoALVO
BofA starts bullish Alvotech coverage on biosimilar launch cycle
Investing.com -- BofA Securities initiated coverage of Alvotech S.A. with a “buy” rating and a $7 price objective, versus the stock’s $4.43 price as of Monday, after the FDA’s closure of its inspection of the company’s Reykjavik manufacturing facility removed a key regulatory overhang and as the biosimilar developer enters what BofA called its most meaningful launch cycle since inception.
Yahoo11 days agoALVO
Napco Security Technologies Posts Upbeat Q4 Results, Joins Alvotech, Rum Group And Other Big Stocks Moving Higher On Monday
The text discusses recent gains in the stock market, particularly for companies like Napco Security Technologies and SuperX AI Technology. US stocks were mixed, with the Dow Jones index gaining 150 points. Napco Security Technologies rose after better-than-expected results. Other big gainers include SuperX AI, Evolution Metals, and Cleveland-Cliffs.
Benzinga11 days agoALVO
B of A Securities Initiates Coverage On Alvotech with Buy Rating, Announces Price Target of $7
B of A Securities analyst Jason Gerberry initiates coverage on Alvotech (NASDAQ:ALVO) with a Buy rating and announces Price Target of $7.
Benzinga11 days agoALVO
Alvotech 2026 Q2 - Results - Earnings Call Presentation
2026-08-21. The following slide deck was published by Alvotech in conjunction with their 2026 Q2 earnings call.
SeekingAlpha14 days agoALVO
Alvotech (ALVO) Q2 2026 Earnings Call Transcript
Alvotech (ALVO) Q2 2026 Earnings Call August 20, 2026 8:00 AM EDTCompany ParticipantsBenedikt Stefansson - Vice President of Investor Relations & Global...
SeekingAlpha15 days agoALVO
Alvotech Q2 2026 Earnings Call Transcript
Alvotech (NASDAQ:ALVO) reported second-quarter financial results on Thursday. The transcript from the company's second-quarter earnings call has been provided below. This content is powered by Benzinga APIs. For
Benzinga15 days agoALVO
Alvotech Q2 EPS $(0.17) Misses $(0.04) Estimate, Sales $106.000M Miss $111.010M Estimate
Alvotech (NASDAQ:ALVO) reported quarterly losses of $(0.17) per share which missed the analyst consensus estimate of $(0.04) by 325 percent. This is a 221.43 percent decrease over earnings of $0.14 per share from the
Benzinga16 days agoALVO
Alvotech Affirms FY2026 Sales Guidance of $650.000M-$700.000M vs $644.838M Est
Alvotech (NASDAQ:ALVO) affirms FY2026 sales outlook from $650.000 million-$700.000 million to $650.000 million-$700.000 million vs $644.838 million estimate.
Benzinga16 days agoALVO
Evercore ISI Group Initiates Coverage On Alvotech with Outperform Rating
Evercore ISI Group analyst Umer Raffat initiates coverage on Alvotech (NASDAQ:ALVO) with a Outperform rating.
Benzinga21 days agoALVO
X4 Pharmaceuticals (XFOR) Reports Q2 Loss, Beats Revenue Estimates
X4 Pharmaceuticals (XFOR) delivered earnings and revenue surprises of +31.58% and +340.30%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Yahoo28 days agoALVO